183 related articles for article (PubMed ID: 34646828)
1. An Advanced Systems Pharmacology Strategy Reveals
Zhou W; Wu C; Zhao C; Huang Z; Lu S; Fan X; Tan Y; Stalin A; You R; Liu X; Zhang J; Wu Z; Wu J
Front Cell Dev Biol; 2021; 9():742421. PubMed ID: 34646828
[TBL] [Abstract][Full Text] [Related]
2. Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology.
Zhou W; Wu J; Zhu Y; Meng Z; Liu X; Liu S; Ni M; Jia S; Zhang J; Guo S
BMC Complement Med Ther; 2020 Jan; 20(1):6. PubMed ID: 32020871
[TBL] [Abstract][Full Text] [Related]
3. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
[TBL] [Abstract][Full Text] [Related]
4. Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathway.
Li L; Wang K; Liu Z; Lü Y; Wang C; Yi X; Guo J
World J Surg Oncol; 2022 May; 20(1):161. PubMed ID: 35590327
[TBL] [Abstract][Full Text] [Related]
5. A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation.
Wu C; Huang ZH; Meng ZQ; Fan XT; Lu S; Tan YY; You LM; Huang JQ; Stalin A; Ye PZ; Wu ZS; Zhang JY; Liu XK; Zhou W; Zhang XM; Wu JR
Chin Med; 2021 Nov; 16(1):121. PubMed ID: 34809653
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.
Zhang LH; Zhang WY; Xiong JM; Duan XM; Hai LN; Zhang YL; Zhang MM; Qin GF; Zhang GW
Chin J Nat Med; 2022 Jan; 20(1):43-53. PubMed ID: 35101249
[TBL] [Abstract][Full Text] [Related]
7. Compound Kushen Injection inhibits epithelial-mesenchymal transition of gastric carcinoma by regulating VCAM1 induced by the TNF signaling pathway.
Huang Z; Wu C; Zhou W; Lu S; Tan Y; Wu Z; You R; Stalin A; Guo F; Zhang J; Liu P; Wang W; Duan X; You L; Wu J
Phytomedicine; 2023 Sep; 118():154984. PubMed ID: 37487253
[TBL] [Abstract][Full Text] [Related]
8. Elucidating the pharmacological effects of Compound Kushen injection on MYC-P15-CCND1 signaling pathway in nasopharyngeal carcinoma - An in vitro study.
Wu Z; Wu C; Shi J; Huang Z; Lu S; Tan Y; You R; Hai L; Huang J; Guo S; Gao Y; Jin Z; Tao X; You L; Wu J
J Ethnopharmacol; 2023 Oct; 315():116702. PubMed ID: 37257705
[TBL] [Abstract][Full Text] [Related]
9. A Bioinformatics Research on Novel Mechanism of Compound Kushen Injection for Treating Breast Cancer by Network Pharmacology and Molecular Docking Verification.
Liu S; Hu X; Fan X; Jin R; Yang W; Geng Y; Wu J
Evid Based Complement Alternat Med; 2020; 2020():2758640. PubMed ID: 32849897
[TBL] [Abstract][Full Text] [Related]
10. Integrated bioinformatics analysis to decipher molecular mechanism of compound Kushen injection for esophageal cancer by combining WGCNA with network pharmacology.
Zhou W; Wu J; Zhang J; Liu X; Guo S; Jia S; Zhang X; Zhu Y; Wang M
Sci Rep; 2020 Jul; 10(1):12745. PubMed ID: 32728182
[TBL] [Abstract][Full Text] [Related]
11. Exploring the nucleotide molecular mechanism of compound kushen injection for lung adenocarcinoma based on network pharmacology and molecular docking.
Ye Z; Yao X; Chen Z; Jin Q; You Q
Front Oncol; 2022; 12():1013052. PubMed ID: 36419898
[TBL] [Abstract][Full Text] [Related]
12. A metabolic data-driven systems pharmacology strategy for decoding and validating the mechanism of Compound Kushen Injection against HCC.
Wang KX; Chen YP; Lu AP; Du GH; Qin XM; Guan DG; Gao L
J Ethnopharmacol; 2021 Jun; 274():114043. PubMed ID: 33753143
[TBL] [Abstract][Full Text] [Related]
13. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect.
He R; Ou S; Chen S; Ding S
Med Sci Monit; 2020 Jan; 26():e918520. PubMed ID: 31892693
[TBL] [Abstract][Full Text] [Related]
14. Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation.
Gao L; Wang KX; Zhou YZ; Fang JS; Qin XM; Du GH
Sci Rep; 2018 Jan; 8(1):624. PubMed ID: 29330507
[TBL] [Abstract][Full Text] [Related]
15. Exploring the pharmacological mechanism of compound kushen injection in the treatment of breast cancer using
Ye Y; Zhang B; Liang Q; Wang D; Bai F; Li Y; Wei L; Li L; Huang H; Tang Y
Front Oncol; 2022; 12():946758. PubMed ID: 36016606
[TBL] [Abstract][Full Text] [Related]
16. A System Pharmacology Model for Decoding the Synergistic Mechanisms of Compound Kushen Injection in Treating Breast Cancer.
Li Y; Wang K; Chen Y; Cai J; Qin X; Lu A; Guan D; Qin G; Chen W
Front Pharmacol; 2021; 12():723147. PubMed ID: 34899291
[TBL] [Abstract][Full Text] [Related]
17. Molecular Evidence of Compound Kushen Injection Against Lung Cancer: A Network Pharmacology-Based Investigation from Western Medicine to Traditional Medicine.
Liang S; Li Y; Zhang X; Guo Y; Pan S
Anticancer Agents Med Chem; 2021; 21(15):2012-2022. PubMed ID: 33573576
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Compound Kushen Injection for the Treatment of Lung Cancer Based on Network Pharmacology.
Meng Z; Liu X; Wu J; Zhou W; Wang K; Jing Z; Liu S; Ni M; Zhang X
Evid Based Complement Alternat Med; 2019; 2019():4637839. PubMed ID: 31275410
[TBL] [Abstract][Full Text] [Related]
19. The feasibility of using the compound kushen injection to treat cervical cancer based on network pharmacology and transcriptomics.
Zhang Y; Xu L; Li L
Medicine (Baltimore); 2023 Sep; 102(36):e35135. PubMed ID: 37682145
[TBL] [Abstract][Full Text] [Related]
20. High Throughput Transcriptome Data Analysis and Computational Verification Reveal Immunotherapy Biomarkers of Compound Kushen Injection for Treating Triple-Negative Breast Cancer.
Liu X; Wu Y; Zhang Y; Bu D; Wu C; Lu S; Huang Z; Song Y; Zhao Y; Guo F; Ye P; Fu C; Shen L; Zhang J; Wang H; Duan X; Wu J
Front Oncol; 2021; 11():747300. PubMed ID: 34604090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]